Efficacy of Extended-Release Liposomal Bupivacaine for Post-Operative Pain Management Following Urogynecologic Surgery: A Prospective, Randomized, Double-Blinded, Placebo-Controlled Trial
Phase of Trial: Phase IV
Latest Information Update: 03 Jun 2016
At a glance
- Drugs Bupivacaine (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- 23 May 2016 Planned End Date changed from 1 Sep 2016 to 1 Nov 2016.
- 23 May 2016 Planned primary completion date changed from 1 Sep 2016 to 1 Nov 2016.
- 13 Nov 2014 New trial record